ILSI Europe hosts, sponsors, and co-organises a variety of scientific events. These include independent symposia, workshops, webinars, hands-on scientific trainings and sessions held as part of the program of larger scientific conferences or professional meetings.
Vitafoods Europe 2026 is one of the world's leading events for the nutraceutical industry, bringing together the entire health and nutrition ecosystem under one roof. Taking place from 5-7 May 2026 in Barcelona, the event connects ingredient suppliers, manufacturers, brands, and industry experts from across the globe.
With a strong focus on innovation, science, and market trends, Vitafoods Europe offers a dynamic platform to discover new products, gain insights through high-level conferences, and build meaningful partnerships. From functional ingredients to finished products, it showcases the latest developments shaping the future of health and wellness.
ILSI Europe's sessions
Panel Discussion | Do all paths lead to the gut? NPD opportunities driven by gut connections - Wednesday, May 6, 2026 1:30 PM to 2:10 PM · 40 min. (Europe/Paris) Conference Theatre, 5A6
We have often heard, "we are what we eat." Emerging science now shows this is not just a saying but a biological reality, with the gut acting as a central communication hub influencing multiple systems in the body. The gut has rapidly become the powerhouse of health, with more research emerging to support its role in influencing mood, cognition, immunity, and metabolic health among others. For the nutraceutical industry, this raises an important question: are gut-mediated pathways where NPD opportunities lie? This panel will explore the latest science linking gut health to broader physiological systems and discuss the rise of microbiome-targeted ingredients. We will examine where the evidence is strongest versus where hype may outpace data. Join experts as they debate whether the gut is truly the industry's ultimate hub.
ILSI Europe's ambassador Bruno Pot (Yakult Europe) will participate in the panel.
Beyond the injection: Microbiome, GLP-1 and the new reality of weight management - Thursday, May 7, 2026 12:05 PM to 12:45 PM · 40 min. (Europe/Paris) Conference Theatre, 5A6
GLP-1 therapies are reshaping weight management but what role does the microbiome play in optimising outcomes? This session explores how probiotics and prebiotics may complement GLP-1-driven pathways in metabolic regulation and appetite control. Moving beyond mechanisms, it brings in the consumer reality: what people actually experience while on GLP-1 medications, and what this means for product development. Industry-relevant insights will highlight opportunities, limitations, and unmet needs, while identifying key knowledge gaps and priority research questions to guide innovation in nutrition solutions aligned with this rapidly evolving landscape.
The session, moderated by our Exective and Scientific Director Isabelle Guelinckx, will feature two presentations delivered by ILSI Europe experts Kelly Dowson (F!S Group) and Keiran Tuohy (Leeds University).
Vitafoods Europe 2026 is one of the world's leading events for the nutraceutical industry, bringing together the entire health and nutrition ecosystem under one roof. Taking place from 5-7 May 2026 in Barcelona, the event connects ingredient suppliers, manufacturers, brands, and industry experts from across the globe.
With a strong focus on innovation, science, and market trends, Vitafoods Europe offers a dynamic platform to discover new products, gain insights through high-level conferences, and build meaningful partnerships. From functional ingredients to finished products, it showcases the latest developments shaping the future of health and wellness.
ILSI Europe's sessions
Panel Discussion | Do all paths lead to the gut? NPD opportunities driven by gut connections - Wednesday, May 6, 2026 1:30 PM to 2:10 PM · 40 min. (Europe/Paris) Conference Theatre, 5A6
We have often heard, "we are what we eat." Emerging science now shows this is not just a saying but a biological reality, with the gut acting as a central communication hub influencing multiple systems in the body. The gut has rapidly become the powerhouse of health, with more research emerging to support its role in influencing mood, cognition, immunity, and metabolic health among others. For the nutraceutical industry, this raises an important question: are gut-mediated pathways where NPD opportunities lie? This panel will explore the latest science linking gut health to broader physiological systems and discuss the rise of microbiome-targeted ingredients. We will examine where the evidence is strongest versus where hype may outpace data. Join experts as they debate whether the gut is truly the industry's ultimate hub.
ILSI Europe's ambassador Bruno Pot (Yakult Europe) will participate in the panel.
Beyond the injection: Microbiome, GLP-1 and the new reality of weight management - Thursday, May 7, 2026 12:05 PM to 12:45 PM · 40 min. (Europe/Paris) Conference Theatre, 5A6
GLP-1 therapies are reshaping weight management but what role does the microbiome play in optimising outcomes? This session explores how probiotics and prebiotics may complement GLP-1-driven pathways in metabolic regulation and appetite control. Moving beyond mechanisms, it brings in the consumer reality: what people actually experience while on GLP-1 medications, and what this means for product development. Industry-relevant insights will highlight opportunities, limitations, and unmet needs, while identifying key knowledge gaps and priority research questions to guide innovation in nutrition solutions aligned with this rapidly evolving landscape.
The session, moderated by our Exective and Scientific Director Isabelle Guelinckx, will feature two presentations delivered by ILSI Europe experts Kelly Dowson (F!S Group) and Keiran Tuohy (Leeds University).
This site uses cookies to provide you with a personalized browsing experience. By clicking “I Agree” or continuing to use the site you agree to allow cookies to be placed and accept the terms set out in our [Privacy Notice]. Please read the Privacy Notice for more information on how we handle information collected from users and how you can control the use of such information.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.